BACKGROUND: Reduced expression of connexin43 (Cx43) and sodium channel (Nav1.5) and increased expression of collagen (fibrosis) are important determinants of impulse conduction in the heart. OBJECTIVE: To study the importance and interaction of these factors at very low Cx43 expression, inducible Cx43 knockout mice with and without inducible ventricular tachycardia (VT) were compared through electrophysiology and immunohistochemistry. METHODS: Cx43(CreER(T)/fl) mice were induced with tamoxifen and killed after 2 weeks. Epicardial activation mapping was performed on Langendorff-perfused hearts, and arrhythmia vulnerability was tested. Mice were divided into arrhythmogenic (VT+; n = 13) and nonarrhythmogenic (VT-; n = 10) animals, and heart tissue was analyzed for Cx43, Nav1.5, and fibrosis. RESULTS: VT+ mice had decreased Cx43 expression with increased global, but not local, heterogeneity of Cx43 than did VT- mice. Nav1.5-immunoreactive protein expression was lower in VT+ than in VT- mice, specifically at sites devoid of Cx43. Levels of fibrosis were similar between VT- and VT+ mice. QRS duration was increased and epicardial activation was more dispersed in VT+ mice than in VT- mice. The effective refractory period was similar between the 2 groups. Premature stimulation resulted in a more severe conduction slowing in VT+ than in VT- hearts in the right ventricle. Separate patch-clamp experiments in isolated rat ventricular myocytes confirmed that the loss of Cx43 expression correlated with the decreased sodium current amplitude. CONCLUSIONS: Global heterogeneity in Cx43 expression and concomitant heterogeneous downregulation of sodium-channel protein expression and sodium current leads to slowed and dispersed conduction, which sensitizes the heart for ventricular arrhythmias.
BACKGROUND: Reduced expression of connexin43 (Cx43) and sodium channel (Nav1.5) and increased expression of collagen (fibrosis) are important determinants of impulse conduction in the heart. OBJECTIVE: To study the importance and interaction of these factors at very low Cx43 expression, inducible Cx43 knockout mice with and without inducible ventricular tachycardia (VT) were compared through electrophysiology and immunohistochemistry. METHODS:Cx43(CreER(T)/fl) mice were induced with tamoxifen and killed after 2 weeks. Epicardial activation mapping was performed on Langendorff-perfused hearts, and arrhythmia vulnerability was tested. Mice were divided into arrhythmogenic (VT+; n = 13) and nonarrhythmogenic (VT-; n = 10) animals, and heart tissue was analyzed for Cx43, Nav1.5, and fibrosis. RESULTS: VT+ mice had decreased Cx43 expression with increased global, but not local, heterogeneity of Cx43 than did VT- mice. Nav1.5-immunoreactive protein expression was lower in VT+ than in VT- mice, specifically at sites devoid of Cx43. Levels of fibrosis were similar between VT- and VT+ mice. QRS duration was increased and epicardial activation was more dispersed in VT+ mice than in VT- mice. The effective refractory period was similar between the 2 groups. Premature stimulation resulted in a more severe conduction slowing in VT+ than in VT- hearts in the right ventricle. Separate patch-clamp experiments in isolated rat ventricular myocytes confirmed that the loss of Cx43 expression correlated with the decreased sodium current amplitude. CONCLUSIONS: Global heterogeneity in Cx43 expression and concomitant heterogeneous downregulation of sodium-channel protein expression and sodium current leads to slowed and dispersed conduction, which sensitizes the heart for ventricular arrhythmias.
Authors: Mohamed Boulaksil; Stephan K G Winckels; Markus A Engelen; Mèra Stein; Toon A B van Veen; John A Jansen; André C Linnenbank; Marti F A Bierhuizen; W Antoinette Groenewegen; Matthijs F M van Oosterhout; Johannes H Kirkels; Nicolaas de Jonge; András Varró; Marc A Vos; Jacques M T de Bakker; Harold V M van Rijen Journal: Eur J Heart Fail Date: 2010-06-09 Impact factor: 15.534
Authors: Carmen R Valdivia; William W Chu; Jielin Pu; Jason D Foell; Robert A Haworth; Mathew R Wolff; Timothy J Kamp; Jonathan C Makielski Journal: J Mol Cell Cardiol Date: 2005-03 Impact factor: 5.000
Authors: Priscila Y Sato; Hassan Musa; Wanda Coombs; Guadalupe Guerrero-Serna; Gustavo A Patiño; Steven M Taffet; Lori L Isom; Mario Delmar Journal: Circ Res Date: 2009-08-06 Impact factor: 17.367
Authors: L La Vecchia; R Ometto; F Bedogni; G Finocchi; G M Mosele; L Bozzola; P Bevilacqua; M Vincenzi Journal: Am J Cardiol Date: 1998-03-15 Impact factor: 2.778
Authors: Mèra Stein; Toon A B van Veen; Carol Ann Remme; Mohamed Boulaksil; Maartje Noorman; Leonie van Stuijvenberg; Roel van der Nagel; Connie R Bezzina; Richard N W Hauer; Jacques M T de Bakker; Harold V M van Rijen Journal: Cardiovasc Res Date: 2009-04-22 Impact factor: 10.787
Authors: Thomas Desplantez; Megan L McCain; Philippe Beauchamp; Ghislaine Rigoli; Barbara Rothen-Rutishauser; Kevin Kit Parker; Andre G Kleber Journal: Cardiovasc Res Date: 2012-01-27 Impact factor: 10.787
Authors: Hiroki Takanari; Vincent J A Bourgonje; Magda S C Fontes; Antonia J A Raaijmakers; Helen Driessen; John A Jansen; Roel van der Nagel; Bart Kok; Leonie van Stuijvenberg; Mohamed Boulaksil; Yoshio Takemoto; Masatoshi Yamazaki; Yukiomi Tsuji; Haruo Honjo; Kaichiro Kamiya; Itsuo Kodama; Mark E Anderson; Marcel A G van der Heyden; Harold V M van Rijen; Toon A B van Veen; Marc A Vos Journal: Cardiovasc Res Date: 2016-06-29 Impact factor: 10.787
Authors: Jacqueline Fannin; Kevin M Rice; Srininvas Thulluri; Lucy Dornon; Ravi Kumar Arvapalli; Paulette Wehner; Eric R Blough Journal: Age (Dordr) Date: 2014-07-27
Authors: Brian Skriver Nielsen; Daniel Bloch Hansen; Bruce R Ransom; Morten Schak Nielsen; Nanna MacAulay Journal: Neurochem Res Date: 2017-04-22 Impact factor: 3.996
Authors: J Matthew Rhett; Rengasayee Veeraraghavan; Steven Poelzing; Robert G Gourdie Journal: Trends Cardiovasc Med Date: 2013-03-11 Impact factor: 6.677